Denali Therapeutics Inc. (DNLI)
South San Francisco, CA
Total Compensation for Fiscal Year Ending in 2024: $6,557,662
| Salary | $690,100 |
|---|---|
| Bonus | $627,969 |
| Value of Stock Awards | $1,819,942 |
| Value of Option Awards | $3,405,851 |
| Non-Equity Incentive Plan Compensation | $0 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $13,800 |
| Total | $6,557,662 |
Denali Therapeutics Inc. disclosed its CEO pay was
19
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
